ALNYLAM PHARMACEUTICALS, INC. (ALNY) Current Reports & Earnings Releases
Upcoming
- 2026-10-29 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-05-27 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2026-04-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-04 | 8-K | Officer / Director Changes | SEC |
| 2026-02-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Results of Operations | SEC |
| 2025-12-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-03 | 8-K | Officer / Director Changes | SEC |
| 2025-10-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-03 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-09-12 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-10 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Officer / Director Changes | SEC |
| 2025-05-13 | 8-K | Charter Amendments, Shareholder Vote Results | SEC |
| 2025-05-01 | 8-K | Financial Statements & Exhibits | SEC |
| 2025-03-21 | 8-K | Other Events | SEC |
| 2025-03-05 | 8-K | Officer / Director Changes | SEC |
| 2025-02-13 | 8-K | Financial Statements & Exhibits | SEC |
| 2025-01-13 | 8-K | Results of Operations | SEC |
| 2024-10-31 | 8-K | Financial Statements & Exhibits | SEC |
| 2024-08-01 | 8-K | Financial Statements & Exhibits | SEC |
| 2024-05-20 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-02 | 8-K | Financial Statements & Exhibits | SEC |
| 2024-03-04 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-02-15 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-19 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-01-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.